HS

Harpreet Singh Khunger

Active Director Additional Director DIN 10522815
DIN 10522815 First appointment Mar 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Harpreet Singh Khunger

Data last updated:

Harpreet Singh Khunger is an Additional Director at Ajs Hospital Private Limited (since 2024). The company operates in Healthcare.

DIN 10522815
Primary Designation Additional Director
Industry Healthcare
First Appointment 01 Mar 2024
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ajs Hospital Private Limited U85194PB2018PTC047415
Additional Director01 Mar 20242018Active

Board colleagues of Harpreet Singh Khunger

NameDINCompanyDesignation
Darshan Singh10522804Ajs Hospital Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Ajs Hospital Private Limited
Premium access

Shareholding and investment profile for Harpreet Singh Khunger

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harpreet Singh Khunger

Harpreet Singh Khunger currently holds 1 directorship: Ajs Hospital Private Limited (Additional Director, since 01 Mar 2024).

Harpreet Singh Khunger was first appointed on 01 Mar 2024 as Additional Director at Ajs Hospital Private Limited.

The current boards of Harpreet Singh Khunger's companies include Darshan Singh (Ajs Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available